InterOcean Capital Group LLC Makes New Investment in Humana Inc. (NYSE:HUM)

InterOcean Capital Group LLC purchased a new position in Humana Inc. (NYSE:HUM) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 1,712 shares of the insurance provider’s stock, valued at approximately $784,000.

Other hedge funds have also bought and sold shares of the company. Dorsey & Whitney Trust CO LLC raised its holdings in Humana by 2.6% during the 3rd quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock valued at $397,000 after buying an additional 21 shares during the period. First Financial Corp IN grew its holdings in Humana by 7.2% during the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock valued at $157,000 after purchasing an additional 23 shares during the last quarter. Walker Financial Services Inc. grew its holdings in Humana by 3.9% during the 4th quarter. Walker Financial Services Inc. now owns 795 shares of the insurance provider’s stock valued at $364,000 after purchasing an additional 30 shares during the last quarter. Signaturefd LLC lifted its stake in Humana by 1.2% in the fourth quarter. Signaturefd LLC now owns 2,634 shares of the insurance provider’s stock worth $1,206,000 after purchasing an additional 30 shares during the last quarter. Finally, Brighton Jones LLC grew its stake in shares of Humana by 6.8% during the fourth quarter. Brighton Jones LLC now owns 470 shares of the insurance provider’s stock valued at $215,000 after buying an additional 30 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Down 0.9 %

HUM traded down $3.19 during trading on Thursday, hitting $353.41. The stock had a trading volume of 406,373 shares, compared to its average volume of 1,912,797. The company has a market capitalization of $42.59 billion, a PE ratio of 22.20, a PEG ratio of 2.07 and a beta of 0.50. Humana Inc. has a twelve month low of $298.61 and a twelve month high of $530.54. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. The stock has a 50 day simple moving average of $322.50 and a two-hundred day simple moving average of $373.47.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, topping the consensus estimate of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business had revenue of $29.61 billion during the quarter, compared to the consensus estimate of $28.52 billion. During the same period in the previous year, the firm posted $9.38 earnings per share. The business’s revenue for the quarter was up 10.7% compared to the same quarter last year. On average, research analysts predict that Humana Inc. will post 16.18 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.00%. Humana’s payout ratio is currently 22.04%.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of recent analyst reports. Royal Bank of Canada reduced their target price on Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a research note on Thursday, April 25th. Stephens dropped their target price on shares of Humana from $550.00 to $430.00 and set an “overweight” rating on the stock in a research note on Friday, January 26th. Jefferies Financial Group decreased their price target on shares of Humana from $411.00 to $381.00 and set a “buy” rating for the company in a research note on Monday, April 22nd. The Goldman Sachs Group dropped their price objective on Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. Finally, Raymond James began coverage on Humana in a research report on Friday, March 22nd. They set a “market perform” rating for the company. Eleven research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $426.39.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.